Foundayo: Eli Lilly's New Oral Weight Loss Pill
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys new weight loss pill, Foundayo, is set to hit the market this Monday, offering a once-daily alternative to weekly injectables. Priced at $25 per month for insured patients with a coupon, its expected to generate nearly $15 billion by 2030. Foundayos ease of use and flexibility could attract new users, particularly seniors on Medicare, and compete with Novo Nordisks Wegovy. Lilly plans to expand globally and develop a full lineup of obesity treatments.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/ad0655bcea6d1981